Adenosine A2Areceptor antagonist istradefylline (KW-6002) reduces “off” time in Parkinson's disease: A double-blind, randomized, multicenter clinical trial (6002-US-005)-Reference-Cited by-同舟云学术

Adenosine A2Areceptor antagonist istradefylline (KW-6002) reduces “off” time in Parkinson's disease: A double-blind, randomized, multicenter clinical trial (6002-US-005)

Published:2008-03 Issue:3 Volume:63 Page:295-302
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

LeWitt Peter A.,Guttman M.,Tetrud James W.,Tuite Paul J.,Mori Akihisa,Chaikin Philip,Sussman Neil M.,

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ana.21315/fullpdf

Reference24 articles.

1. Clinical practice. Diagnosis and initial management of Parkinson's disease;Nutt;N Engl J Med,2005

2. Impact of sustained deprenyl (selegiline) in levodopa-treated Parkinson's disease: a randomized placebo-controlled extension;Shoulson;Ann Neurol,2002

3. Pramipexole vs. levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial;Parkinson Study Group;Arch Neurol,2004

4. Pathophysiology of motor fluctuations in Parkinson's disease;Widnell;Mov Disord,2005

Cited by 313 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors associated with a placebo effect in Parkinson’s disease in clinical trials: a meta-analysis;Journal of Neurology;2024-07-02

2. Istradefylline Safety Profiles: Examination of Individual Case Safety Reports in the FDA Adverse Event Reporting System (FAERS) Database;2024-04-02

3. Screening and Targeting Risk Factors for Prodromal Synucleinopathy: Taking Steps toward a Prescriptive Multi-modal Framework;aging and disease;2024

4. Apomorphine Sublingual Film Compared with Subcutaneous Apomorphine for OFF Episodes in Parkinson’s Disease: An Open-Label, Randomized, Crossover Study;Journal of Parkinson's Disease;2023-12-19

5. Management of OFF condition in Parkinson disease;Mental Health Clinician;2023-12-01